Tuesday, November 3, 2026
TagsTherapeutics

Tag: Therapeutics

Healthcare

Halia Therapeutics to Present Final Phase 2 Ofirnoflast Data in Lower-Risk MDS at EHA2026 and Announces Appointment of Han Myint, MD, FACP, as Chief...

Ravindra Soni - 0
Healthcare

CorFlow Therapeutics Announces Successful Completion of Phase 1 and First Patients Enrolled in Phase 2 of the MOCA II Pivotal Trial, Approval to Start...

Ravindra Soni - 0
Healthcare

SynSmart and Amporin Announce Collaboration to Develop Breakthrough Small Molecule Therapeutics for Degenerative Diseases

Ravindra Soni - 0
Healthcare

Orthogon Therapeutics Raises an Additional $11M Financing for Its BK Virus Antiviral Drug Program

Ravindra Soni - 0
Healthcare

AnBogen Therapeutics to Present Dual Breakthroughs for Imofinostat (ABT-301) at AACR 2026: Addressing Immunotherapy Barriers in CRC and Chemo-resistance in Pancreatic Cancer

Ravindra Soni - 0
Healthcare

Basecamp Research Launches Trillion Gene Atlas to Scale AI-Designed Therapeutics

Ravindra Soni - 0
Healthcare

Halia Therapeutics Announces Presentation at the BIO Investment & Growth Summit

Ravindra Soni - 0
Corporate

BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology Leadership

Ravindra Soni - 0
Healthcare

Polaroid Therapeutics (PTx) Receives CE Mark for POLTX_Fiber™: the first application of APT™ to launch a new standard in wound care

Ravindra Soni - 0
Healthcare

Angelini Pharma and Quiver Bioscience Announce Strategic Research Collaboration and Licensing Agreement to Discover and Advance Novel Therapeutics for Genetic Epilepsies

Ravindra Soni - 0
123...7Page 1 of 7

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

BusinessFortnight (businessfortnight.com) is an Indian digital news and media platform that covers business, economy, banking, insurance, real estate, automobiles, aviation, and hospitality news

Contact us: editorbusinessfortnight(@)gmail.com

© BusinessFortnight.com. All Rights Reserved.